Zobrazit minimální záznam

Secukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritis

dc.contributor.authorHauer, Lukáš
dc.contributor.authorMoztarzadeh, Omid
dc.contributor.authorBaghalipour, Nasimeh
dc.contributor.authorGenčur, Jiří
dc.date.accessioned2024-11-05T08:11:22Z
dc.date.available2024-11-05T08:11:22Z
dc.date.issued2024
dc.identifier.urihttps://hdl.handle.net/20.500.14178/2677
dc.description.abstractThe use of antiangiogenic and antiresorptive medications, particularly in patients with cancer or osteoporosis, can lead to osteonecrosis of the jaw following tooth extraction, trauma or arising spontaneously- A condition known as medication-related osteonecrosis of the jaw (MRONJ). In this article, we present a unique case of MRONJ in a patient with no history of antiresorptive or antiangiogenic drug use, who was instead taking the anti-interleukin 17-A (Secukinumab) medication for severe psoriasis. This association has not been previously reported in the literature.en
dc.language.isoen
dc.relation.urlhttps://www.dovepress.com/article/download/95893
dc.rightsCreative Commons Uveďte původ-Neužívejte dílo komerčně 3.0 Unportedcs
dc.rightsCreative Commons Attribution-NonCommercial 3.0 Unporteden
dc.titleSecukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritisen
dcterms.accessRightsopenAccess
dcterms.licensehttps://creativecommons.org/licenses/by-nc/3.0/legalcode
dc.date.updated2024-11-05T08:11:22Z
dc.subject.keywordplaque psoriasisen
dc.subject.keywordanti-interleukin 17-Aen
dc.subject.keywordimmunomodulatoren
dc.subject.keywordinterleukins inhibitorsen
dc.subject.keywordMRONJen
dc.subject.keyworden
dc.identifier.eissn2230-326X
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/FN/I-FN/I-FNP-08
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/I-UK/I-LFP
dc.date.embargoStartDate2024-11-05
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.2147/PTT.S490982
dc.identifier.utWos001319532000001
dc.identifier.obd653491
dc.identifier.pubmed39347517
dc.subject.rivPrimary30000::30200::30208
dcterms.isPartOf.namePsoriasis
dcterms.isPartOf.issn2230-326X
dcterms.isPartOf.journalYear2024
dcterms.isPartOf.journalVolume14
dcterms.isPartOf.journalIssue23 September 2024
uk.faculty.primaryId111
uk.faculty.primaryNameLékařská fakulta v Plznics
uk.faculty.primaryNameFaculty of Medicine in Pilsenen
uk.faculty.secondaryId54
uk.faculty.secondaryNameFakultní nemocnice Plzeňcs
uk.faculty.secondaryNameUniversity Hospital in Pilsenen
uk.department.primaryId1435
uk.department.primaryNameStomatologická klinikacs
uk.department.primaryNameDepartment of Stomatologyen
uk.department.secondaryId5000002730
uk.department.secondaryId1344
uk.department.secondaryNameStomatologická klinikacs
uk.department.secondaryNameDepartment of Stomatologyen
uk.department.secondaryNameÚstav anatomiecs
uk.department.secondaryNameDepartment of Anatomyen
dc.description.pageRange115-120
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::kazuistikacs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::casuisticsen
dc.type.obdHierarchyCode73::152::202en
uk.displayTitleSecukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritisen


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam